GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper chelate found in human plasma, saliva, and urine. Plasma levels of GHK-Cu decline significantly with age — from approximately 200 ng/mL at age 20 to roughly 80 ng/mL by age 60. This age-related decline correlates with reduced skin repair capacity, collagen synthesis, and wound healing efficiency, making GHK-Cu one of the most biologically grounded peptides for skin rejuvenation applications.

This protocol covers both topical and injectable approaches, wound healing applications, hair growth protocols, and practical combination strategies with complementary agents.

Mechanism overview

GHK-Cu's effects on skin are mediated through multiple converging pathways, which distinguishes it from single-mechanism cosmetic ingredients.

Collagen remodeling: GHK-Cu stimulates collagen synthesis (types I and III) while simultaneously activating metalloproteinases (MMPs) that degrade damaged, disorganized collagen. This dual action is critical — adding new collagen to a matrix of damaged collagen produces inferior results. GHK-Cu promotes the replacement cycle: remove damaged extracellular matrix, then rebuild with properly organized new collagen.

Glycosaminoglycan synthesis: GHK-Cu increases production of decorin, a proteoglycan that regulates collagen fibril assembly and spacing. It also stimulates synthesis of other glycosaminoglycans that maintain skin hydration and structural integrity.

Anti-inflammatory signaling: GHK-Cu suppresses inflammatory cytokines (IL-6, TNF-alpha) and reduces oxidative damage markers. Chronic low-grade skin inflammation (inflammaging) is a primary driver of premature aging, making this anti-inflammatory action synergistic with the collagen-remodeling effects.

Stem cell and tissue repair signaling: GHK-Cu activates genes associated with stem cell proliferation and tissue remodeling. Gene expression studies have identified over 4,000 genes modulated by GHK-Cu, with a net pattern that resembles the gene expression profile of younger tissue.

Copper delivery: The copper ion itself is essential for lysyl oxidase activity (collagen and elastin cross-linking), superoxide dismutase (antioxidant defense), and cytochrome c oxidase (mitochondrial energy production in skin cells). GHK serves as a bioavailable delivery vehicle for copper to the tissues where it is needed.

Topical protocol

Product selection

Concentration: 0.1-1% GHK-Cu in a suitable carrier formulation. Products at the lower end (0.1-0.2%) are widely available as commercial serums. Higher concentrations (0.5-1%) are available through compounding pharmacies or specialty peptide skincare lines.

Formulation matters: GHK-Cu is sensitive to pH (optimal stability at pH 5.0-6.5) and is incompatible with certain preservatives and low-pH actives. A well-formulated serum in a stable base with appropriate pH buffering will outperform a higher-concentration product in a poor vehicle.

Color indicator: Properly formulated GHK-Cu solutions have a characteristic blue tint from the copper complex. If the product is colorless, the copper may have dissociated from the peptide, reducing efficacy.

Daily topical routine

Morning application:

Cleanse with a gentle, pH-balanced cleanser (pH 5.0-6.0)
Apply GHK-Cu serum to damp skin — 3-5 drops for the face, additional drops for the neck and decolletage
Allow 2-3 minutes for absorption before layering subsequent products
Apply moisturizer
Apply broad-spectrum sunscreen (SPF 30+). Non-negotiable — collagen remodeling without UV protection is counterproductive

Evening application:

Double cleanse if wearing sunscreen/makeup (oil-based cleanser followed by water-based cleanser)
Apply GHK-Cu serum to damp skin
Wait 15-20 minutes before applying retinol/retinoid if used in the same routine (see retinol timing section below)
Apply moisturizer or occlusive night cream

Duration: Continuous daily use. Unlike injectable peptides, topical GHK-Cu does not require cycling. The peptide is replenishing what the skin naturally produces in diminishing quantities with age.

Retinol timing and compatibility

Retinol (vitamin A) and GHK-Cu are both powerful skin remodeling agents, but they operate optimally at different pH ranges. Retinol products are typically formulated at pH 5.5-6.5, which overlaps with GHK-Cu's stability range, making them broadly compatible.

Recommended approach: Apply GHK-Cu first. Wait 15-20 minutes for absorption and skin pH stabilization. Then apply retinol. This sequencing allows each product to interact with the skin in its active form before the next layer is applied.

Alternative approach: Use GHK-Cu in the morning and retinol in the evening. This eliminates any potential interaction concerns entirely and is the simplest protocol for individuals new to peptide skincare.

Avoid combining GHK-Cu with: Direct acids at pH below 3.5 (glycolic acid peels, high-concentration vitamin C at low pH). These can destabilize the copper-peptide complex. If using vitamin C, choose a formulation at pH 5.0-6.0 (such as magnesium ascorbyl phosphate or ascorbyl glucoside) rather than L-ascorbic acid at pH 2.5-3.5.

Injectable protocol

Injectable GHK-Cu provides systemic delivery of the peptide-copper complex, producing both skin-specific and broader tissue regeneration effects. The injectable route delivers higher effective concentrations to the dermis than topical application can achieve.

Dose selection

Standard dose: 1-2 mg per day, subcutaneous injection

Conservative start: 1 mg daily for the first week, increasing to 2 mg if well-tolerated

Typical dose for skin rejuvenation: 1-2 mg daily

Wound healing dose: 2 mg daily, potentially with additional local application (topical) at the wound site

Body weight does not significantly influence dosing for skin rejuvenation applications. The 1-2 mg range represents the commonly used window based on practitioner experience and extrapolation from preclinical data.

Route and injection sites

Route: Subcutaneous injection

Primary site for skin rejuvenation: Abdominal subcutaneous tissue. While the injection is not local to the face, systemic circulation delivers GHK-Cu to the dermal vasculature throughout the body.

For localized applications: Some practitioners inject subcutaneously near the target area (e.g., periorbital region for under-eye skin, scalp for hair growth). Periorbital injections should only be performed by trained medical professionals due to the delicate anatomy.

Needle gauge: 29-31 gauge, 0.5-inch insulin syringe

Timing: No strong evidence for morning vs. evening superiority. Consistency matters more than specific timing.

Cycle structure for injectable GHK-Cu

Standard cycle: 4-8 weeks

Assessment point: Week 4. Evaluate skin texture, hydration, and any specific targets (scar improvement, wound healing progress).

Rest period: 4 weeks between cycles

Typical annual use: 2-3 cycles per year for maintenance after initial results

During the rest period, continue topical GHK-Cu application to maintain dermal copper peptide levels through the non-injectable phase.

Wound healing protocol

GHK-Cu is one of the most evidence-supported peptides for wound healing. Preclinical studies demonstrate accelerated wound closure, improved angiogenesis at wound margins, reduced scarring, and enhanced tensile strength of healed tissue.

Acute wound management:

Injectable: 2 mg daily subcutaneous for 2-4 weeks, starting as soon as practical after injury (post-acute phase, once bleeding is controlled and infection risk is managed)
Topical: Apply 0.5-1% GHK-Cu serum directly to the wound bed once it has progressed past the initial inflammatory phase (typically day 3-5 post-injury). Apply twice daily under appropriate wound dressing.

Post-surgical scarring:

Begin topical application once sutures are removed and the incision line is sealed (typically 10-14 days post-surgery, with surgeon approval)
Injectable: 1-2 mg daily for 4-6 weeks starting 2 weeks post-surgery
Continue topical application for 3-6 months to support the full collagen remodeling phase of scar maturation

Burn recovery:

Topical application to second-degree burn sites once the acute inflammatory phase resolves
Injectable protocol: 2 mg daily for 6-8 weeks
Monitor carefully for infection — copper peptides should not be applied to infected wounds

Hair growth protocol

GHK-Cu supports hair growth through multiple mechanisms: increasing follicle size, stimulating proliferation of follicular keratinocytes, extending the anagen (growth) phase, and improving blood supply to the dermal papilla.

Topical scalp application:

Apply 0.5-1% GHK-Cu serum directly to the scalp in areas of thinning
1 mL applied with a dropper, distributed across the treatment area
Once daily, preferably in the evening (allows overnight absorption without cosmetic concerns)
Massage gently for 1-2 minutes to enhance penetration and stimulate local blood flow
Minimum 3-month commitment — hair follicle cycling means visible results require sustained intervention

Injectable for hair (advanced):

1-2 mg subcutaneous injection to the scalp, distributed across the thinning area (mesotherapy-style)
Performed by a medical professional, weekly for 8-12 sessions
This approach delivers GHK-Cu directly to the dermal papilla at higher concentrations than topical application can achieve

Combination for hair: GHK-Cu topical + minoxidil. Apply GHK-Cu in the evening and minoxidil in the morning (or vice versa) to avoid product interaction. The mechanisms are complementary — GHK-Cu addresses follicle biology and extracellular matrix support while minoxidil provides vasodilation and potassium channel activation.

Combination strategies

GHK-Cu + collagen peptides (oral)

Rationale: GHK-Cu stimulates endogenous collagen synthesis and remodeling. Oral collagen peptides (hydrolyzed collagen, typically 5-15 g daily) provide the amino acid substrate (particularly glycine, proline, and hydroxyproline) needed to actually build new collagen. Stimulating collagen production without providing raw materials may limit results; providing raw materials without the signaling to direct tissue remodeling is similarly incomplete. The combination addresses both sides.

Protocol:

GHK-Cu: Topical twice daily + injectable 1-2 mg daily during active cycles
Collagen peptides: 10-15 g daily (oral), any time of day, continuously (no cycling required)
Vitamin C: 500-1,000 mg daily (oral). Vitamin C is a required cofactor for prolyl hydroxylase and lysyl hydroxylase, the enzymes that convert proline and lysine into hydroxyproline and hydroxylysine during collagen synthesis. Without adequate vitamin C, collagen production is biochemically limited regardless of peptide or substrate supplementation.

GHK-Cu + BPC-157 (for wound healing)

For complex or slow-healing wounds, combining GHK-Cu's tissue remodeling effects with BPC-157's angiogenic and anti-inflammatory properties provides mechanistic complementarity.

GHK-Cu: 2 mg daily subcutaneous + topical application at wound site
BPC-157: 250-500 mcg daily subcutaneous, near the wound site
Duration: 4-8 weeks depending on healing trajectory

Monitoring

Skin rejuvenation monitoring

Photographic documentation: Standardized photos (same lighting, angle, distance) at baseline, week 4, and week 8 of each injectable cycle. Comparison photos are more reliable than subjective self-assessment for evaluating skin texture and quality changes.

Skin hydration and elasticity: If available, corneometer (hydration) and cutometer (elasticity) measurements provide objective data. Many dermatology and medical aesthetics practices offer these assessments.

Subjective assessment: Track skin texture, firmness, fine line appearance, and overall radiance on a consistent scale. Compare week 1 vs. week 4 vs. week 8. Most individuals notice textural improvement (smoother, more "polished" skin surface) before visible wrinkle reduction.

Wound healing monitoring

Wound dimensions (length, width, depth) measured weekly
Photography of wound bed color and granulation tissue quality
Time to re-epithelialization compared to expected timeline for wound type and location

Hair growth monitoring

Standardized scalp photography at baseline and every 4 weeks
Hair density counts if dermatological trichoscopy is available
Subjective assessment of hair shedding (daily hair loss count) and hair quality (thickness, texture)

Safety considerations

Topical GHK-Cu: Very well-tolerated. Contact sensitivity is rare. The copper content at recommended concentrations is far below levels that would cause copper toxicity. Mild transient skin warmth or flushing after application is occasionally reported and is considered a normal response to increased local blood flow.

Injectable GHK-Cu: Injection site reactions (redness, mild bruising) are the most common adverse effect. Systemic adverse effects are rare at standard doses. Nausea is occasionally reported at higher doses.

Copper considerations: Individuals with Wilson's disease (genetic copper accumulation disorder) should not use GHK-Cu in any form. For individuals with normal copper metabolism, the amount of copper delivered by GHK-Cu (topical or injectable at standard doses) does not meaningfully alter systemic copper levels. Copper blood levels do not need to be monitored during standard topical use. For prolonged injectable use (repeated 8-week cycles), a baseline serum copper and ceruloplasmin level is reasonable.

Drug interactions: No significant pharmacological interactions reported. GHK-Cu does not interact with common medications, retinoids, or other skincare actives at the systemic level. Topical incompatibilities (low-pH acids) are formulation-related, not drug interactions.

Pregnancy and breastfeeding: No safety data for injectable GHK-Cu. Topical application at cosmetic concentrations (0.1-0.2%) is generally considered low-risk, but conservative practice is to avoid all peptide products during pregnancy and lactation.

Protocol summary

Parameter	Topical	Injectable
Dose	0.1-1% serum, 3-5 drops	1-2 mg daily
Route	Topical to skin	Subcutaneous
Frequency	Twice daily	Once daily
Cycle length	Continuous (no cycling)	4-8 weeks
Rest period	N/A	4 weeks between cycles
Onset of visible effects	4-8 weeks	2-4 weeks
Key combination	Retinol (evening), collagen peptides (oral)	BPC-157 (wound healing)
Monitoring	Standardized photos, skin elasticity	Photos + bloodwork (copper, if prolonged)